Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 11, 2023Endocrine Metabolic & Immune Disorders - Drug Targets

Diabetics' rate of respiratory function deterioration is two to three-times higher than that of normal, non-smoking people, and hyperglycemia is linked to pulmonary fibrosis.

View Full Paper
Ask AI
Bookmark
Share

Why the study?

The diabetic lung has been identified as a possible target organ in diabetes, but very few previous reviews have focused on diabetic pneumopathy and its pathophysiology.

Design

Review

Authors

JDJyotsana DwivediPWPranay WalBDBiswajit Dash

Discussion

Loading...

Member takes

Overview

May prompt lung function monitoring in diabetes; leaves open prospective trials on mechanisms and interventions.

Structured PICO

P
Population
Patients with type 1 and type 2 diabetes
O
Outcome
Diabetic pneumopathy and pulmonary dysfunction

Diabetes is associated with accelerated deterioration of respiratory function and pulmonary fibrosis, highlighting the 'diabetic lung' as a target organ.

Cite This Study

Dwivedi et al. (2023) studied this question.

synapsesocial.com/papers/6a6feb9675498292b7094ca6https://doi.org/10.2174/0118715303265960230926113201
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Diabetic Pulmopathy: A New Clinical Challenge for Diabetology2018 · 6 citations
  2. 2Is the Lung a 'Target Organ' in Diabetes Mellitus?1990 · 163 citations
  3. 3Diabetes mellitus and the lungs2020 · 2 citations
  4. 4Pulmonary complications in diabetes mellitus2008 · 50 citations
  5. 5Current understanding of the pathogenetic relationships between chronic obstructive pulmonary disease and type 2 diabetes mellitus: an integrative review2025